PL1901717T3 - Proszek rozpadający się w jamie ustnej zawierający cilostazol i mannitol - Google Patents

Proszek rozpadający się w jamie ustnej zawierający cilostazol i mannitol

Info

Publication number
PL1901717T3
PL1901717T3 PL06780772T PL06780772T PL1901717T3 PL 1901717 T3 PL1901717 T3 PL 1901717T3 PL 06780772 T PL06780772 T PL 06780772T PL 06780772 T PL06780772 T PL 06780772T PL 1901717 T3 PL1901717 T3 PL 1901717T3
Authority
PL
Poland
Prior art keywords
cilostazol
mannitol
orally disintegrating
disintegrating powder
powder
Prior art date
Application number
PL06780772T
Other languages
English (en)
Inventor
Masafumi Toda
Tadashi Mukai
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of PL1901717T3 publication Critical patent/PL1901717T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL06780772T 2005-06-29 2006-06-28 Proszek rozpadający się w jamie ustnej zawierający cilostazol i mannitol PL1901717T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005190156 2005-06-29
EP06780772A EP1901717B1 (en) 2005-06-29 2006-06-28 Orally disintegrating powder comprising cilostazol and mannitol
PCT/JP2006/313345 WO2007001086A1 (en) 2005-06-29 2006-06-28 Orally disintegrating powder comprising cilostazol and mannitol

Publications (1)

Publication Number Publication Date
PL1901717T3 true PL1901717T3 (pl) 2012-12-31

Family

ID=37120411

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06780772T PL1901717T3 (pl) 2005-06-29 2006-06-28 Proszek rozpadający się w jamie ustnej zawierający cilostazol i mannitol

Country Status (18)

Country Link
US (1) US20090110737A1 (pl)
EP (1) EP1901717B1 (pl)
JP (1) JP4131747B2 (pl)
KR (1) KR101302293B1 (pl)
CN (1) CN101212955B (pl)
AR (1) AR057413A1 (pl)
AU (1) AU2006263068B2 (pl)
CA (1) CA2608629C (pl)
CY (1) CY1113164T1 (pl)
DK (1) DK1901717T3 (pl)
ES (1) ES2388613T3 (pl)
MY (1) MY147888A (pl)
PL (1) PL1901717T3 (pl)
PT (1) PT1901717E (pl)
RU (1) RU2426529C2 (pl)
SI (1) SI1901717T1 (pl)
TW (1) TWI383809B (pl)
WO (1) WO2007001086A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2560899T3 (es) 2007-09-14 2016-02-23 Wockhardt Limited Composiciones de diacereína
WO2009107864A2 (en) * 2008-02-29 2009-09-03 Otsuka Pharmaceutical Co., Ltd. An orally disintegrating tablet
US20150141517A1 (en) * 2013-11-15 2015-05-21 Shin-Etsu Chemical Co., Ltd. Granulated composite, rapid release tablet and method for producing same
KR101748215B1 (ko) * 2015-05-29 2017-06-20 한국유나이티드제약 주식회사 경구용 서방성 제제
RU2694233C2 (ru) * 2017-10-13 2019-07-10 Федеральное государственное унитарное предприятие "Государственный научно-исследовательский институт особо чистых биопрепаратов" Федерального медико-биологического агентства Средство, обладающее ноотропным воздействием на организм

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029878A (en) * 1975-05-19 1977-06-14 Ici United States Inc. Process for preparing mannitol from glucose
ES2082723B1 (es) * 1994-07-20 1996-10-01 Lilly Sa Formulacion farmaceutica de fluoxetina en forma dispersable.
SE9803240D0 (sv) * 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
EG23951A (en) * 1999-03-25 2008-01-29 Otsuka Pharma Co Ltd Cilostazol preparation
CA2374760A1 (en) * 1999-06-18 2000-12-28 Takeda Chemical Industries, Ltd. Quickly disintegrating solid preparations
RU2216319C1 (ru) * 1999-11-30 2003-11-20 Панацея Биотек Лимитед Быстрорастворимая фармацевтическая композиция в виде твердой лекарственной формы с пролонгированным сладким вкусом и способ ее получения
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
JP2003238393A (ja) * 2002-02-15 2003-08-27 Otsuka Pharmaceut Co Ltd 施錠性が改善された錠剤及びその製造方法
CA2478101A1 (en) * 2002-03-06 2003-09-12 Kyowa Hakko Kogyo Co., Ltd. Intraorally rapidly disintegrable tablets
ES2199061B1 (es) * 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
CN1913876B (zh) * 2003-12-09 2013-06-26 大日本住友制药株式会社 含药物的颗粒和包含这种颗粒的固体制剂
PL385455A1 (pl) * 2005-04-22 2008-11-24 Teva Pharmaceuticals Usa,Inc. Doustna rozpadająca się farmaceutyczna tabletka preparatów olanzapiny

Also Published As

Publication number Publication date
WO2007001086A1 (en) 2007-01-04
KR20080021158A (ko) 2008-03-06
SI1901717T1 (sl) 2012-10-30
DK1901717T3 (da) 2012-08-20
ES2388613T3 (es) 2012-10-16
AU2006263068A1 (en) 2007-01-04
AR057413A1 (es) 2007-12-05
RU2426529C2 (ru) 2011-08-20
EP1901717A1 (en) 2008-03-26
AU2006263068B2 (en) 2011-08-18
JP2008528442A (ja) 2008-07-31
MY147888A (en) 2013-01-31
JP4131747B2 (ja) 2008-08-13
CA2608629A1 (en) 2007-01-04
CN101212955A (zh) 2008-07-02
KR101302293B1 (ko) 2013-09-03
HK1119063A1 (en) 2009-02-27
TW200740469A (en) 2007-11-01
CN101212955B (zh) 2012-07-18
CA2608629C (en) 2013-11-19
EP1901717B1 (en) 2012-07-18
CY1113164T1 (el) 2016-04-13
RU2008103213A (ru) 2009-08-10
US20090110737A1 (en) 2009-04-30
TWI383809B (zh) 2013-02-01
PT1901717E (pt) 2012-08-07

Similar Documents

Publication Publication Date Title
PL385229A1 (pl) Sposoby i związki pośrednie
GB0707077D0 (en) End mill
EP1889195A4 (en) PRODUCTION-DESIGN DESIGN AND DESIGNED PRODUCTION
EP1857489A4 (en) MICROPARTICLE AND PHARMACEUTICAL COMPOSITION
EP1787978A4 (en) DIIMMONIUM COMPOUND AND USE THEREOF
IL191072A0 (en) Therapeutic compositions and methods
IL162587A0 (en) Torsionally-stiff end mill
GB0512940D0 (en) Compounds and their use
IL189252A0 (en) Dihydroxyanthraquinones and their use
EP1890677A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE
IL185223A0 (en) Compounds and uses thereof
GB0516069D0 (en) Pharmaceutical and use thereof
GB0520743D0 (en) Compounds and their use
IL186337A0 (en) Stannsoporfin compositions and administration
PL1901717T3 (pl) Proszek rozpadający się w jamie ustnej zawierający cilostazol i mannitol
PL1868727T3 (pl) Młynek do kości
PT2474528E (pt) Compostos antineoplásicos e composições farmacêuticas dos mesmos
GB0501348D0 (en) Compositions and methods
EP1865777A4 (en) STANNSOPORFIN COMPOSITIONS AND ADMINISTRATION
ZA200804378B (en) Iminopropene compound and use thereof
GB0502843D0 (en) Jig-was and jig-will
AU157610S (en) Pepper mill
GB0517239D0 (en) Geogrotren-mk1-system and project
GB0522259D0 (en) e-s-spi-l-d-film-cinema-back-engineering armageddon-system and project
GB0517240D0 (en) Chronorotron mk1-system and project